Literature DB >> 24846449

Vitamin D and cognitive function and dementia risk in a biracial cohort: the ARIC Brain MRI Study.

A L C Schneider1, P L Lutsey, A Alonso, R F Gottesman, A R Sharrett, K A Carson, M Gross, W S Post, D S Knopman, T H Mosley, E D Michos.   

Abstract

BACKGROUND AND
PURPOSE: Some recent studies in older, largely white populations suggest that vitamin D, measured by 25-hydroxyvitamin D [25(OH)D], is important for cognition, but such results may be affected by reverse causation. Measuring 25(OH)D in late middle age before poor cognition affects behavior may provide clearer results.
METHODS: This was a prospective cohort analysis of 1652 participants (52% white, 48% black) in the Atherosclerosis Risk in Communities (ARIC) Brain MRI Study. 25(OH)D was measured from serum collected in 1993-1995. Cognition was measured by the delayed word recall test (DWRT), the digit symbol substitution test (DSST) and the word fluency test (WFT). Dementia hospitalization was defined by ICD-9 codes. Adjusted linear, logistic and Cox proportional hazards models were used.
RESULTS: Mean age of participants was 62 years and 60% were female. Mean 25(OH)D was higher in whites than blacks (25.5 vs. 17.3 ng/ml, P < 0.001). Lower 25(OH)D was not associated with lower baseline scores or with greater DWRT, DSST or WFT decline over a median of 3 or 10 years of follow-up (P > 0.05). Over a median of 16.6 years, there were 145 incident hospitalized dementia cases. Although not statistically significant, lower levels of 25(OH)D were suggestive of an association with increased dementia risk [hazard ratio for lowest versus highest race-specific tertile: whites 1.32 (95% confidence interval 0.69, 2.55); blacks 1.53 (95% confidence interval 0.84, 2.79)].
CONCLUSIONS: In contrast to prior studies performed in older white populations, our study of late middle age white and black participants did not find significant associations between lower levels of 25(OH)D with lower cognitive test scores at baseline, change in scores over time or dementia risk.
© 2014 The Author(s) European Journal of Neurology © 2014 EAN.

Entities:  

Keywords:  ARIC study; cognition; dementia; vitamin D

Mesh:

Substances:

Year:  2014        PMID: 24846449      PMCID: PMC4114998          DOI: 10.1111/ene.12460

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  34 in total

Review 1.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

2.  UK Food Standards Agency Workshop Report: an investigation of the relative contributions of diet and sunlight to vitamin D status.

Authors:  Margaret Ashwell; Elaine M Stone; Heiko Stolte; Kevin D Cashman; Helen Macdonald; Susan Lanham-New; Sara Hiom; Ann Webb; David Fraser
Journal:  Br J Nutr       Date:  2010-06-04       Impact factor: 3.718

3.  The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes.

Authors:  Giuseppe Pugliese; Anna Solini; Enzo Bonora; Emanuela Orsi; Gianpaolo Zerbini; Francesco Giorgino; Franco Cavalot; Antonio E Pontiroli; Marco G Baroni; Susanna Morano; Antonio Nicolucci; Giuseppe Penno
Journal:  Atherosclerosis       Date:  2011-05-06       Impact factor: 5.162

4.  A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease.

Authors:  Mark S Stein; Samuel C Scherer; Kylie S Ladd; Leonard C Harrison
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

5.  Incidence and prevalence of dementia in the Cardiovascular Health Study.

Authors:  Annette L Fitzpatrick; Lewis H Kuller; Diane G Ives; Oscar L Lopez; William Jagust; John C S Breitner; Beverly Jones; Constantine Lyketsos; Corinne Dulberg
Journal:  J Am Geriatr Soc       Date:  2004-02       Impact factor: 5.562

Review 6.  Vitamin D and cardiovascular disease risk.

Authors:  Erin D Michos; Michal L Melamed
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-01       Impact factor: 4.294

7.  Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease.

Authors:  C Oudshoorn; F U S Mattace-Raso; N van der Velde; E M Colin; T J M van der Cammen
Journal:  Dement Geriatr Cogn Disord       Date:  2008-05-26       Impact factor: 2.959

Review 8.  The association between vitamin D and cognition: a systematic review.

Authors:  J van der Schaft; H L Koek; E Dijkstra; H J J Verhaar; Y T van der Schouw; M H Emmelot-Vonk
Journal:  Ageing Res Rev       Date:  2013-05-29       Impact factor: 10.895

9.  Calcium and vitamin D supplementation and cognitive impairment in the women's health initiative.

Authors:  Rebecca C Rossom; Mark A Espeland; Joann E Manson; Maurice W Dysken; Karen C Johnson; Dorothy S Lane; Erin S LeBlanc; Frank A Lederle; Kamal H Masaki; Karen L Margolis
Journal:  J Am Geriatr Soc       Date:  2012-11-23       Impact factor: 5.562

10.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

View more
  18 in total

1.  Vitamin D Status and Intakes and Their Association With Cognitive Trajectory in a Longitudinal Study of Urban Adults.

Authors:  May A Beydoun; Sharmin Hossain; Marie T Fanelli-Kuczmarski; Hind A Beydoun; Jose-Atilio Canas; Michele K Evans; Alan B Zonderman
Journal:  J Clin Endocrinol Metab       Date:  2018-04-01       Impact factor: 5.958

2.  Vitamin D Insufficiency and Cognitive Function Trajectories in Older Adults: The Rancho Bernardo Study.

Authors:  Gail A Laughlin; Donna Kritz-Silverstein; Jaclyn Bergstrom; Emilie T Reas; Simerjot K Jassal; Elizabeth Barrett-Connor; Linda K McEvoy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Serum Vitamin D Concentrations and Cognitive Change Over 20 Years: The Atherosclerosis Risk in Communities Neurocognitive Study.

Authors:  Andrea L C Schneider; Di Zhao; Pamela L Lutsey; Rebecca F Gottesman; A Richey Sharrett; Andreea M Rawlings; Alvaro Alonso; David Knopman; Thomas H Mosley; Elizabeth Selvin; Erin D Michos
Journal:  Neuroepidemiology       Date:  2018-08-09       Impact factor: 3.282

4.  Vitamin D status, cognitive decline and incident dementia: the Canadian Study of Health and Aging.

Authors:  Caroline S Duchaine; Denis Talbot; Mohamed Nafti; Yves Giguère; Sylvie Dodin; André Tourigny; Pierre-Hugues Carmichael; Danielle Laurin
Journal:  Can J Public Health       Date:  2020-02-03

5.  Serum 25-hydroxyvitamin D is associated with reduced verbal episodic memory in healthy, middle-aged and older adults.

Authors:  Virginie Lam; Matthew A Albrecht; Ryusuke Takechi; Prachya Prasopsang; Ya Ping Lee; Jonathan K Foster; John C L Mamo
Journal:  Eur J Nutr       Date:  2015-07-01       Impact factor: 5.614

6.  Low 25-Hydroxyvitamin D Concentrations and Risk of Incident Cognitive Impairment in Black and White Older Adults: The Health ABC Study.

Authors:  Laurel Kilpatrick; Denise K Houston; Valerie K Wilson; James Lovato; Hilsa N Ayonayon; Jane A Cauley; Tamara Harris; Eleanor M Simonsick; Kristine Yaffe; Stephen B Kritchevsky; Kaycee M Sink
Journal:  J Nutr Gerontol Geriatr       Date:  2018-03-05

7.  Vitamin D and Age-Related Health Outcomes: Movement, Mood, and Memory.

Authors:  Denise K Houston
Journal:  Curr Nutr Rep       Date:  2015-05-08

8.  Brain Aging in African-Americans: The Atherosclerosis Risk in Communities (ARIC) Experience.

Authors:  Rebecca F Gottesman; Myriam Fornage; David S Knopman; Thomas H Mosley
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

9.  Evaluation of cognitive subdomains, 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D in the European Male Ageing Study.

Authors:  Margot J Overman; Neil Pendleton; Terence W O'Neill; Gyorgy Bartfai; Felipe F Casanueva; Joseph D Finn; Gianni Forti; Giulia Rastrelli; Aleksander Giwercman; Thang S Han; Ilpo T Huhtaniemi; Krzysztof Kula; Michael E J Lean; Margus Punab; David M Lee; Elon S Correa; Tomas Ahern; Sabine M P Verschueren; Leen Antonio; Evelien Gielen; Martin K Rutter; Dirk Vanderschueren; Frederick C W Wu; Jos Tournoy
Journal:  Eur J Nutr       Date:  2016-07-01       Impact factor: 5.614

10.  Association of parathyroid hormone with 20-year cognitive decline: The ARIC study.

Authors:  Samuel M Kim; Di Zhao; Andrea L C Schneider; Sai Krishna Korada; Pamela L Lutsey; Eliseo Guallar; Alvaro Alonso; B Gwen Windham; Rebecca F Gottesman; Erin D Michos
Journal:  Neurology       Date:  2017-08-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.